# A Pharmacogenomics Study for Breast Cancer Patients Undergoing Adjuvant Chemotherapy With Doxorubicin (A)/Cyclophosphamide ©) and/or Weekly Paclitaxel

> **NCT00131963** · — · COMPLETED · sponsor: **Duke University** · enrollment: 94 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** cyclophosphamide
- **DRUG:** doxorubicin
- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT00131963
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2016-07-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00131963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00131963, "A Pharmacogenomics Study for Breast Cancer Patients Undergoing Adjuvant Chemotherapy With Doxorubicin (A)/Cyclophosphamide ©) and/or Weekly Paclitaxel". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00131963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*